Standard dynamic
- Notice of Intent to Revise：<1099> Limit on Number of Large Deviations When Assessing Content Uniformity in Large Samples
2019-01-25 10:26:55.0 - New Pending Notice of Intent to Revise Abiraterone Acetate Tablets
2019-01-25 10:26:39.0 - New Pending Notice of Intent to Revise: Azithromycin Tablets
2019-01-25 10:25:32.0 - New Pending Notice of Intent to Revise: Lamotrigine Extended-Release Tablets
2019-01-25 10:24:59.0 - New Pending Notice of Intent to Revise: Methylphenidate Hydrochloride Extended-Release Tablets (posted 25–Jan–2019)
2019-01-25 10:24:26.0 - New Pending Notice of Intent to Revise: Olmesartan Medoxomil Tablets
2019-01-25 10:24:06.0 - Notice of Intent to Revise：Phytonadione (Cancellation of Postponement)
2018-12-28 10:42:00.0 - Notice of Intent to Revise: Revisions to Plastics Packaging Chapters <659>, <661>, <661.1>, <661.2>, and <1661>
2018-12-28 10:41:24.0 - Notice of Intent to Revise：Dronedarone Tablets
2018-12-28 10:41:01.0 - New Pending Notice of Intent to Revise: Fluticasone Propionate and Salmeterol Inhalation Powder
2018-12-13 10:40:11.0